JPWO2019222796A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019222796A5 JPWO2019222796A5 JP2020565274A JP2020565274A JPWO2019222796A5 JP WO2019222796 A5 JPWO2019222796 A5 JP WO2019222796A5 JP 2020565274 A JP2020565274 A JP 2020565274A JP 2020565274 A JP2020565274 A JP 2020565274A JP WO2019222796 A5 JPWO2019222796 A5 JP WO2019222796A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- chimeric antigen
- receptor
- amino acid
- antigen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018901782A AU2018901782A0 (en) | 2018-05-21 | Chimeric Antigen Receptors with Modified Linker Domain and uses thereof | |
| AU2018901782 | 2018-05-21 | ||
| PCT/AU2019/050487 WO2019222796A1 (en) | 2018-05-21 | 2019-05-20 | Chimeric antigen receptors with modified linker domains and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021524248A JP2021524248A (ja) | 2021-09-13 |
| JPWO2019222796A5 true JPWO2019222796A5 (https=) | 2022-05-16 |
| JP2021524248A5 JP2021524248A5 (https=) | 2022-05-16 |
Family
ID=68615492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565274A Pending JP2021524248A (ja) | 2018-05-21 | 2019-05-20 | 修飾されたリンカードメインを有するキメラ抗原受容体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220089718A1 (https=) |
| EP (1) | EP3797164A4 (https=) |
| JP (1) | JP2021524248A (https=) |
| KR (1) | KR20210013691A (https=) |
| CN (1) | CN112166193A (https=) |
| AU (1) | AU2019275479B2 (https=) |
| BR (1) | BR112020023489A8 (https=) |
| CA (1) | CA3099712A1 (https=) |
| MX (1) | MX2020012445A (https=) |
| SG (1) | SG11202010451QA (https=) |
| WO (1) | WO2019222796A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3347474B1 (en) | 2015-09-11 | 2020-11-04 | Biosceptre (UK) Limited | Chimeric antigen receptors and uses thereof |
| JP2022551975A (ja) * | 2019-10-15 | 2022-12-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｆｃ封鎖を介する移植細胞保護 |
| CN111944062B (zh) * | 2019-12-09 | 2023-11-07 | 深圳市体内生物医药科技有限公司 | 一种识别Fc片段的嵌合抗原受体及其应用 |
| WO2021163035A1 (en) * | 2020-02-12 | 2021-08-19 | Sab, Llc. | Anti-thymocyte globulin |
| EP4204005A1 (en) | 2020-08-31 | 2023-07-05 | Sab, Llc | Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof |
| JP2024510739A (ja) * | 2021-03-11 | 2024-03-11 | バイオセプター （オースト） プロプライエタリー・リミテッド | 新規な細胞治療システム |
| MX2023015028A (es) * | 2021-09-01 | 2024-02-16 | Biosceptre Aust Pty Ltd | Nuevos aglutinantes del p2x7 disfuncional. |
| JP2025508371A (ja) * | 2022-02-11 | 2025-03-26 | フレッド ハッチンソン キャンサー センター | Ｓｔｅａｐ１に結合するキメラ抗原受容体 |
| CA3267581A1 (en) * | 2022-09-14 | 2024-03-21 | Biosceptre (Aust) Pty Ltd | IN VIVO DETECTION OF IMMUNE CELLS |
| US20260085104A1 (en) * | 2022-09-14 | 2026-03-26 | Biosceptre (Aust) Pty Ltd | Methods of detecting immune cells |
| EP4587465A1 (en) * | 2022-09-14 | 2025-07-23 | Biosceptre (Aust) Pty Ltd | Enrichment of engineered immune cells |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4940661A (en) | 1984-05-17 | 1990-07-10 | Genentech, Inc. | Metallothionein transcription control sequences and use thereof |
| US5512483A (en) | 1993-05-21 | 1996-04-30 | Mcgill University | Expression vectors responsive to steroid hormones |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| CA2219121A1 (en) | 1995-05-26 | 1996-11-28 | Zeneca Limited | A gene switch comprising an ecdysone receptor |
| US5851796A (en) | 1995-06-07 | 1998-12-22 | Yale University | Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
| AU4533300A (en) | 1999-09-16 | 2001-04-17 | Liangqi Zhang | A pressure-reducing diaphragm of carburettor |
| NZ565994A (en) | 2001-09-03 | 2010-02-26 | Intreat Pty Ltd | Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| AU2005250055B2 (en) | 2004-06-02 | 2008-09-11 | Adalta Pty Ltd | Binding moieties based on shark IgNAR domains |
| WO2008043146A1 (en) | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Antibodies against non functional p2x7 receptor |
| JP2010505426A (ja) | 2006-10-10 | 2010-02-25 | バイオスセプター インターナショナル リミテッド | 非機能性ｐ２ｘ７受容体に対する抗体を産生するハイブリドーマ |
| AU2008299593B2 (en) | 2007-09-14 | 2013-04-18 | Biosceptre International Limited | Novel P2X7 epitopes |
| BRPI0915367B8 (pt) | 2008-07-04 | 2021-05-25 | Biosceptre International Ltd | peptídeo anti-p2x7 |
| ES2904911T3 (es) | 2009-08-20 | 2022-04-06 | Biosceptre Aust Pty Ltd | Anticuerpos anti-receptor P2X7 y fragmentos de los mismos |
| JP5992831B2 (ja) | 2009-12-24 | 2016-09-14 | バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド | 非機能性オリゴマーｐ２ｘ７受容体に対する抗体 |
| ES2754394T3 (es) * | 2010-09-08 | 2020-04-17 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Receptores de antígenos quiméricos con una región bisagra optimizada |
| EP2646461A2 (en) | 2010-12-03 | 2013-10-09 | Cyclogenix Ltd | VARIANTS OF igNAR |
| EP2990416B1 (en) * | 2014-08-29 | 2018-06-20 | GEMoaB Monoclonals GmbH | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
| CN107002084B (zh) * | 2014-09-19 | 2021-09-10 | 希望之城公司 | 靶向IL13Rα2的共刺激嵌合抗原受体T细胞 |
| BR112017011893A2 (pt) * | 2014-12-05 | 2018-07-24 | City Of Hope | células t modificadas no receptor de antígeno quimérico direcionado para cs1 |
| WO2016123143A1 (en) * | 2015-01-26 | 2016-08-04 | The University Of Chicago | CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2 |
| EP3347474B1 (en) * | 2015-09-11 | 2020-11-04 | Biosceptre (UK) Limited | Chimeric antigen receptors and uses thereof |
| US11034767B2 (en) * | 2016-04-15 | 2021-06-15 | Trustees Of Dartmouth College | High affinity B7-H6 antibodies and antibody fragments |
| WO2018017649A1 (en) * | 2016-07-19 | 2018-01-25 | Unum Therapeutics Inc. | Use of antibody-coupled t cell receptor (actr) with multiple anti-cancer antibodies in cancer treatment |
| WO2018064626A1 (en) * | 2016-09-30 | 2018-04-05 | Baylor College Of Medicine | Adaptive chimeric antigen receptor t-cell design |
| EP3315511A1 (en) * | 2016-10-29 | 2018-05-02 | Miltenyi Biotec GmbH | Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens |
-
2019
- 2019-05-20 EP EP19808128.3A patent/EP3797164A4/en active Pending
- 2019-05-20 WO PCT/AU2019/050487 patent/WO2019222796A1/en not_active Ceased
- 2019-05-20 KR KR1020207033662A patent/KR20210013691A/ko not_active Ceased
- 2019-05-20 CN CN201980034413.2A patent/CN112166193A/zh active Pending
- 2019-05-20 MX MX2020012445A patent/MX2020012445A/es unknown
- 2019-05-20 SG SG11202010451QA patent/SG11202010451QA/en unknown
- 2019-05-20 JP JP2020565274A patent/JP2021524248A/ja active Pending
- 2019-05-20 CA CA3099712A patent/CA3099712A1/en active Pending
- 2019-05-20 AU AU2019275479A patent/AU2019275479B2/en active Active
- 2019-05-20 US US17/057,060 patent/US20220089718A1/en active Pending
- 2019-05-20 BR BR112020023489A patent/BR112020023489A8/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524248A5 (https=) | ||
| US20240228636A1 (en) | mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS | |
| Labrijn et al. | Bispecific antibodies: a mechanistic review of the pipeline | |
| JP7797198B2 (ja) | ヒトｐｄ－１に対する二機能性分子 | |
| EP3645742B1 (en) | Anti-ror1 antibodies and methods of making and using thereof | |
| TW202039572A (zh) | 雙官能抗pd-1/il-7分子 | |
| US12116411B2 (en) | Antibodies binding to human CD3 at acidic pH | |
| WO2022104267A1 (en) | Multispecific antibodies and uses thereof | |
| EP3733707A1 (en) | Car t-cells targeting bcma and uses thereof | |
| JPWO2019222796A5 (https=) | ||
| Mohammadi et al. | Immunotherapy For Researchers | |
| JP7558534B2 (ja) | Ｃｄ１３７アゴニスト性抗体とその使用 | |
| US20250101104A1 (en) | Bispecific molecule with tunable affinity to a targeted antigen | |
| JP7725066B2 (ja) | ヒト化抗ｐｄ－ｌ１抗体 | |
| TW202426503A (zh) | 癌症治療中與ｐｄ－１訊息抑制劑組合之抗ｃｌｄｎ４－抗ｃｄ１３７雙特異性抗體的用途 | |
| CN113735973B (zh) | 一种抗SIRPα抗体及其应用 | |
| JP2022553176A (ja) | Ｏｘ４０／ｐｄ－ｌ１二重特異性抗体 | |
| Gupta et al. | Therapeutic human monoclonal antibodies | |
| JP7854121B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| US20250270318A1 (en) | Multispecific antibodies and uses thereof | |
| JP2025087939A (ja) | がん治療におけるｐｄ－１シグナル阻害剤との組み合わせによる抗ｔｓｐａｎ８－抗ｃｄ３二重特異性抗体の使用 | |
| WO2023031300A1 (en) | Personalized vnar-based chimeric antigen receptors (vnar-car) for the treatment of clonal b-and t cell malignancies, and methods for producing vnar-cars | |
| JP2025530110A (ja) | 二重特異性ポリペプチド及びその使用 | |
| CN121693520A (zh) | 靶向肿瘤相关抗原与cd28的双特异性抗体及其应用 | |
| CN121511258A (zh) | 结合构建体 |